Higher risk of tuberculosis in combination therapy for inflammatory bowel disease: A nationwide population-based cohort study in South Korea

Inflammatory bowel disease (IBD) in Asia has become increasingly prevalent. As a treatment of IBD, many immunomodulators and biological agents were introduced and shown to be effective in inducing and maintaining remission. However, many cases with treatment failure were reported. To overcome the fa...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Seong Ji, Kim, Min Sun, Kim, Eun Sun, Lee, Juneyoung, Lee, Jae Min, Choi, Hyuk Soon, Keum, Bora, Jeen, Yoon Tae, Lee, Hong Sik, Chun, Hoon Jai, Kim, Chang Duck
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598778/
https://www.ncbi.nlm.nih.gov/pubmed/33126343
http://dx.doi.org/10.1097/MD.0000000000022897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598778/
https://www.ncbi.nlm.nih.gov/pubmed/33126343
http://dx.doi.org/10.1097/MD.0000000000022897

Ejemplares similares